Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bicara Therapeutics Inc. | 2,204,650 | 2,392,150 | +187,500 | 37,104 | 47,580 | 29.16% | +10,476 |
| Replimune Group(REPL) | 248,672 | 248,672 | 0 | 2,417 | 1,910 | 1.17% | -507 |
| ImageneBio, Inc.(IMA) | 455,361 | 455,361 | 0 | 3,142 | 2,277 | 1.40% | -865 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 3,434 | 2,430 | 1.49% | -1,004 |
| Alumis Inc. | 653,223 | 241,255 | -411,968 | 6,375 | 5,315 | 3.26% | -1,061 |
| enGene Holdings Inc. COM | 876,357 | 876,357 | 0 | 7,914 | 5,968 | 3.66% | -1,946 |
| BridgeBio Oncology Therapeutics Inc.(BBOT) | 3,289,661 | 3,289,661 | 0 | 41,187 | 29,442 | 18.05% | -11,744 |
| Kestra Med Technologies Ltd SHS | 1,373,591 | 1,022,149 | -351,442 | 36,428 | 20,371 | 12.49% | -16,056 |
| Beta Bionics Inc.(BBNX) | 1,316,183 | 1,316,183 | 0 | 40,104 | 13,188 | 8.08% | -26,916 |
| Upstream Bio Inc.(UPB) | 1,326,293 | 0 | -1,326,293 | 36,009 | 0 | — | -36,009 |
| Nuvation Bio Inc.(NUVB) | 8,081,089 | 8,081,089 | 0 | 72,407 | 34,668 | 21.25% | -37,739 |